Hyperhomocystinemia as a thrombotic risk factor in patients sufferlng from systemic Lupus Erithematosus and antiphospholipid syndrome
Objectives: to detect the prevalence of hyperhcy in SLE patients with and without antiphospholipid syndrom; to compare the Hcy leveis between those patients and healthy controis and to determine the correlation between hyperhcy and antiphospholipid antibodies. Patients and methods: we studied 44 SLE...
Guardado en:
| Autores principales: | Onetti, Laura, Villafañe, Susana, Menso, Emilia, Denkard, Cristina, Gamron, Susana, Barberis, Gloria, Onetti, Carlos |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2005
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/32470 |
| Aporte de: |
Ejemplares similares
-
Hyperhomocysteine like risk factor in patient with systemic lupus erythematous with antiphospholipid sindrom
por: Onetti, Laura, et al.
Publicado: (2021) -
Usefulness of the adjusted Global Antiphospholipid Syndrome Score (aGAPSS) to determine thrombotic risk in a cohort of patients with primary antiphospholipid syndrome
por: Quaglia , M I, et al.
Publicado: (2021) -
Antiphospholipid syndrome
por: Alba, Paula, et al.
Publicado: (2011) -
Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome
por: Pelusa, Héctor Fabián, et al.
Publicado: (2017) -
Intracardiac thrombi in antiphospholipid syndrome (APS)
por: Tissera, Y, et al.
Publicado: (2022)